NIH pilot project will match researchers to genes, gene variants of interest

March 1, 2018, NIH/National Human Genome Research Institute
The Genomic Ascertainment Cohort (TGAC) offers a paradigm-shifting approach to studying the phenotypic consequence of human genetic variation. Credit: Darryl Leja, NHGRI.

Databases such as the 1000 Genomes Project and the Exome Aggregation Consortium (ExAC) harbor large numbers of genotypes (an individual's collection of genes). Until now, it has been difficult for researchers to re-contact individuals with genotypes of interest and investigate the health consequences of their genes and gene variants.

To address this challenge, National Institutes of Health and Inova Health System researchers are launching The Genomic Ascertainment Cohort (TGAC), a two-year pilot project that will allow them to recall genotyped people and examine the genes and gene variants' influence on their phenotypes, an individual's observable traits, such as height, eye color or blood type.

The project reverses a long-standing research paradigm of examining a person's traits or symptoms and then searching for genes or gene variants that cause or contribute to them. NIH will establish a new database of 10,000 human genomes and exomes, the 1-2 percent of the that contains protein-coding genes. Once the database is established, NIH and Inova researchers will predict conditions that specific genes or gene variants might produce and test those predictions by re-examining individuals who donated their DNA sequence information to the database. TGAC will be based in the Washington, D.C., area and only people who've expressly given consent to be re-contacted will participate in TGAC.

"We're trying to advance science in a new, creative and slightly radical way," said Leslie Biesecker, M.D., TGAC co-organizer and chief of the Medical Genomics and Metabolic Genetics Branch at NIH's National Human Genome Research Institute (NHGRI). "Our goal is to determine what genes and gene variants do. We're especially interested in using this as a platform to test our ability to predict phenotype from genotype - one of the key underpinnings of predictive genomic medicine." NHGRI will host the database and administer the program.

Participating NIH institutes will each contribute genome and exome sequences from existing research programs to the database, including NHGRI's CLINSEQ program, healthy bone marrow donors from the National Heart, Lung, and Blood Institute's transplant program, the National Institute of Environmental Health Sciences Environmental Polymorphism Study, and others. Inova will contribute genome sequences of 8,000 people in parent-child trios from its Longitudinal Childhood Genome Study.

"Inova is thrilled to be partnering with NIH on this important work," said John E. Niederhuber, M.D., executive vice president and CEO of Inova Translational Medicine Institute. "When we established the Childhood Longitudinal Cohort study at Inova in 2012, this is exactly the vision we had for how such a longitudinal cohort with genomic data would be used to support ground-breaking genomic research."

An additional 1,000 patients will be recruited to have genome sequencing performed. Because knowledge of how genomic variants and their downstream biological effects vary across populations, half of the newly-recruited patients will be individuals from Hispanic backgrounds. They will complement the 500 individuals with African-American ethnic backgrounds in CLINSEQ.

"Ten thousand genomes and exomes is our initial goal because that will allow recruitment of individuals with both common and rarer gene variants," said Richard Siegel, M.D., Ph.D., TGAC co-organizer, clinical director and chief of the Autoimmunity Branch at NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). "This is large-scale sharing of data and research volunteers. We will be taking already sequenced cohorts and making them available to large numbers of researchers."

A researcher might locate a genotype of interest in the database and, if the request is approved, ask participants with the genotype to come to the NIH Clinical Center in Bethesda, Maryland. It is the largest clinical research center in the world with unparalleled phenotyping resources and capabilities. Most of the researchers' requests will require simple blood samples from participants. Other tests might include electroencephalograms (EEG), tests that detect electrical activity in the brain, or MRI scans.

"This is essentially match-making between and gene variants and the researchers who study them," said Dr. Siegel. "We hope they'll provide insights that haven't been possible until now. If successful, we plan to open the database to outside researchers in the future."

Explore further: Integrated variants from 13,000 complete genomes available to public in Kaviar database

Related Stories

Integrated variants from 13,000 complete genomes available to public in Kaviar database

September 23, 2015
The Institute for Systems Biology (ISB) and the Inova Translational Medicine Institute (ITMI) announced today a new release of Kaviar, the most comprehensive collection of human genomic variants currently available to the ...

Team completes atlas of human DNA differences that influence gene expression

October 11, 2017
Researchers funded by the National Institutes of Health (NIH) have completed a detailed atlas documenting the stretches of human DNA that influence gene expression - a key way in which a person's genome gives rise to an observable ...

Linking human genome sequences to health data will change clinical medicine, says expert

April 20, 2017
The value of intersecting the sequencing of individuals' exomes (all expressed genes) or full genomes to find rare genetic variants—on a large scale—with their detailed electronic health record (EHR) information has "myriad ...

Exploring disease predisposition to deliver personalized medicine

October 23, 2017
Geneticists from the University of Geneva have taken an important step towards true predictive medicine. Exploring the links between diseases and tissue-specific gene activity, they have been able to build a model that constitutes ...

Human genome sequences linked to health data will change clinical medicine

December 22, 2016
The value of intersecting the sequencing of individuals' exomes (all expressed genes) or full genomes to find rare genetic variants—on a large scale—with their detailed electronic health record (EHR) information has "myriad ...

New insights into human genetic variation revealed

August 17, 2016
Published in today's edition of Nature, the research led by Dr Monkol Lek of the University of Sydney and Dr Daniel MacArthur of The Broad Institute of MIT and Harvard Universities reveals patterns of genetic variation worldwide ...

Recommended for you

Early life experiences influence DNA in the adult brain

March 22, 2018
In the perennial question of nature versus nurture, a new study suggests an intriguing connection between the two. Salk Institute scientists report in the journal Science that the type of mothering a female mouse provides ...

Study reveals startlingly different tissue sensitivities to cancer-driving genes

March 22, 2018
New research led by Harvard Medical School and Brigham and Women's Hospital has unmasked hundreds of cancer-driving genes and revealed that different tissue types have shockingly variable sensitivities to those genes.

Does genome sequencing increase downstream costs?

March 22, 2018
As genome sequencing enters the clinic, fears have arisen about its potential to motivate follow-up testing and ongoing screening that could drastically increase health care spending. But few studies have quantified the downstream ...

First 'non-gene' mutations behind neurodevelopmental disorders discovered

March 21, 2018
In the largest study of its kind, genetic changes causing neurodevelopmental disorders have been discovered by scientists at the Wellcome Sanger Institute and their collaborators in the NHS Regional Genetics services. The ...

Two genes likely play key role in extreme nausea and vomiting during pregnancy

March 21, 2018
Most women experience some morning sickness during pregnancy, but about 2 percent of pregnant women experience a more severe form of nausea and vomiting.

Scientists identify genes that could inform novel therapies for EBV-related cancers

March 20, 2018
VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer. The discovery could ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.